FDA Inspection
AAA Pharmaceutical, Inc.AAA Pharmaceutical, Inc. – FDA Inspection, Apr 3, 2019
Record Details
This FDA Inspection record concerns AAA Pharmaceutical, Inc., with an inspection on April 3, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e143c598-9a0f-4bd0-850a-c2f61c39964c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1084922
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AAA Pharmaceutical, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 28, 2025 | VAI | New Jersey District Office | Drug Quality Assurance |
| March 14, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AAA Pharmaceutical, Inc.
- FDA Inspection 1253810 - 2025-03-28
- FDA Inspection 868581 - 2014-03-14
- FDA Inspection 817981 - 2013-02-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.